Heron CEO exercises 62,500 RSUs into shares
Heron Therapeutics Chief Executive Officer Craig A. Collard exercised 62,500 restricted stock units into 62,500 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Heron Therapeutics Chief Executive Officer Craig A. Collard exercised 62,500 restricted stock units into 62,500 shares of common stock. The RSUs carried a $0.0000 exercise price and each unit represented a right to receive one share of common stock.
After the transaction, Collard directly owned 648,255 shares of Heron Therapeutics common stock. His holdings include 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025. The restricted stock units vest in four equal annual installments beginning one year after the grant date, contingent on his continued service.
Insider Trade Summary
62,500 shares exercised/converted
Exercise
2 txns
Insider
Collard Craig A
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 62,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 62,500 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 62,500 contracts (Direct);
Common Stock — 648,255 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2. Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025.
- F3. The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.
Key Figures
RSUs exercised: 62,500 units
Shares received from RSUs: 62,500 shares
Exercise price: $0.0000 per share
+2 more
5 metrics
RSUs exercised
62,500 units
Restricted stock units converted to common stock on 2026-04-03
Shares received from RSUs
62,500 shares
Common stock received from RSU exercise on 2026-04-03
Exercise price
$0.0000 per share
Price for conversion of restricted stock units
Post-transaction holdings
648,255 shares
Common stock directly owned after transactions
ESPP shares included
14,045 shares
Acquired under 1997 Employee Stock Purchase Plan on 2025-04-30
Key Terms
Restricted Stock Units, Employee Stock Purchase Plan, vest, derivative security
4 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Purchase Plan financial
"Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
vest financial
"The restricted stock units vest in four equal annual installments beginning one year after the date of grant."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Heron Therapeutics (HRTX) CEO Craig Collard report in this Form 4?
Craig Collard reported exercising 62,500 restricted stock units, receiving 62,500 shares of Heron Therapeutics common stock at a $0.0000 exercise price. Following this transaction, he directly held 648,255 shares, reflecting compensation-related equity rather than an open-market share purchase or sale.
What are the details of the 62,500 restricted stock units exercised at Heron (HRTX)?
The filing shows 62,500 restricted stock units exercised, converting into 62,500 shares of common stock at a $0.0000 exercise price. Each restricted stock unit represents a contingent right to receive one share of common stock, reflecting stock-based compensation rather than a cash-funded stock purchase.
How do Craig Collard’s restricted stock units at Heron (HRTX) vest?
The restricted stock units vest in four equal annual installments, beginning one year after the grant date. Vesting is conditioned on Craig Collard’s continued service to Heron Therapeutics through each vesting date, aligning his long-term incentives with ongoing employment at the company.
What role did the Heron 1997 Employee Stock Purchase Plan play in these holdings?
A footnote explains that Collard’s holdings include 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025. This plan allows eligible employees to purchase company stock, adding to his overall equity position beyond restricted stock units.
Does this Heron (HRTX) Form 4 show any open-market buying or selling by the CEO?
The Form 4 reflects an exercise or conversion of derivative securities, not open-market trades. Transaction code M and the $0.0000 price indicate a derivative exercise of restricted stock units into common shares, with no reported open-market buying or selling of Heron stock in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates